Skip to main content
Caplight Logo









Semdor Pharma Group

Semdor Pharma Group

Private
CologneHealthcare & Life Scienceshttps://semdor-group.com/

Last Round

Corporate Funding

Jan 15, 2021

Total Funding Raised

$48.3M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Semdor Pharma Group is a pharmaceutical company that specializes in narcotics and medical cannabis. Formed through the combination of Cannamedical Pharma GmbH and PS Pharma Group, the company provides a broad range of services including the import, handling, packaging, and distribution of narcotic medicines and medical cannabis products to wholesalers, suppliers, and pharmacies across Europe.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, Biotechnology, Telemedicine, Logistics Software

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

medical marijuananarcotics distributionmedical cannabiscontrolled substancespharma supply chainpharmaceutical logisticspharmaceutical manufacturingpain therapytelemedicine platformonline pharmacymail-order pharmacymedcanGMP certifiedGDP certified

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Semdor Pharma Group Comparables

Compare Semdor Pharma Group with similar companies based on industry and business-model similarity.

Semdor Pharma Group comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SOMAÍ Pharmaceuticals
83%
Cansativa Group
81%
DEMECAN
79%

Semdor Pharma Group Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingJan 15, 2021

Key People

Founding team and executive leadership

David Henn

CEO

Executive Team

Justus Lassnig

Chief Operating Officer

Executive Team

Semdor Pharma Group Investors

Notable investors and investment history

Semdor Pharma Group investors
InvestorRounds
Orkila CapitalCorporate Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors increased 35% MoM, reaching 8.5K.

  • Jul 20, 2026

    Open roles increased to 20, 95% of headcount.

Semdor Pharma Group Filings

Explore SEC and related filing metadata, where available.

Semdor Pharma Group filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Semdor Pharma Group's valuation, stock price, and market status.

Is Semdor Pharma Group a public or private company?

Semdor Pharma Group is a private company.

What is the current stock price of Semdor Pharma Group?

Semdor Pharma Group is a private company with no public stock price. No recent secondary market data is available.

How much is Semdor Pharma Group worth (valuation)?

Valuation information for Semdor Pharma Group is not publicly available.

Can I buy Semdor Pharma Group stock?

Semdor Pharma Group shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Semdor Pharma Group's last funding round?

Funding round information for Semdor Pharma Group is not publicly available.

Who are the main investors in Semdor Pharma Group?

Investor information for Semdor Pharma Group is not publicly disclosed.

Will Semdor Pharma Group IPO soon?

No public IPO plans have been announced for Semdor Pharma Group.

How can I track Semdor Pharma Group secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Semdor Pharma Group's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCologne
Employee Range22
Year Founded2021
Last FundingJan 15, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?